We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

IRS Releases Final Branded Prescription Drug Fee Regulations

28 July 2014

Health Alert

On 24 July 2014, the Internal Revenue Service released final regulations to implement Section 9008 of the Affordable Care Act (as amended by section 1404 of the Health Care Education and Reconciliation Act), which imposes an annual fee on manufacturers and importers of branded prescription drugs based on their sales under specified federal healthcare programs.

Read More: IRS Releases Final Branded Prescription Drug Fee Regulations

The team

Loading data